(Q46035853)

18 December 2017

title

Poor prognostic significance of unamplified chromosome 17 polysomy in invasive breast carcinoma. (English)

1 reference

18 December 2017

author name string

Uma Krishnamurti

1 reference

18 December 2017

Jennifer L Hammers

1 reference

18 December 2017

Folefac D Atem

1 reference

18 December 2017

Patrick D Storto

1 reference

18 December 2017

Jan F Silverman

1 reference

18 December 2017

publication date

24 April 2009

1 reference

18 December 2017

published in

Modern Pathology

1 reference

18 December 2017

volume

1 reference

18 December 2017

issue

1 reference

18 December 2017

page(s)

1044-1048

1 reference

18 December 2017

Localization of the human erbB-2 gene on normal and rearranged chromosomes 17 to bands q12-21.32.

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.61

Stage- and tissue-specific expression of the neu oncogene in rat development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.61

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.61

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.61

The effect of chromosome 17 polysomy on HER-2/neu status in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.61

Clinicopathologic analysis of breast carcinoma with chromosomal aneusomy detected by fluorescence in situ hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.61

Correction for chromosome-17 is critical for the determination of true Her-2/neu gene amplification status in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.61

Impact of polysomy 17 on HER-2/neu immunohistochemistry in breast carcinomas without HER-2/neu gene amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.61

Chromosome 17 aneusomy is associated with poor prognostic factors in invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.61

Polysomy of chromosome 17 in breast cancer tumors showing an overexpression of ERBB2: a study of 175 cases using fluorescence in situ hybridization and immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.61

Polysomy 17 in breast cancer: clinicopathologic significance and impact on HER-2 testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.61

The HER-2/neu receptor tyrosine kinase gene encodes a secreted autoinhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.61

The complexity of genotypic alterations underlying HER2-positive breast cancer: an explanation for its clinical heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.61

The role of the ubiquitination-proteasome pathway in breast cancer: ubiquitin mediated degradation of growth factor receptors in the pathogenesis and treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.61

Protein kinase Calpha determines HER2 fate in breast carcinoma cells with HER2 protein overexpression without gene amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.61

Central HER2 IHC and FISH analysis in a trastuzumab (Herceptin) phase II monotherapy study: assessment of test sensitivity and impact of chromosome 17 polysomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.61

The product of the human c-erbB-2 gene: a 185-kilodalton glycoprotein with tyrosine kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.61

7 January 2021

Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.61

7 January 2021

neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer. Toronto Breast Cancer Study Group

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.61

7 January 2021

Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.61

7 January 2021

HER2 status in early breast cancer: relevance of cell staining patterns, gene amplification and polysomy 17

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.61

7 January 2021

Polysomy 17 in HER-2/neu Status Elaboration in Breast Cancer: Effect on Daily Practice

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.61

7 January 2021

Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.61

7 January 2021

The influence of polysomy 17 on HER2 gene and protein expression in adenocarcinoma of the breast: a fluorescent in situ hybridization, immunohistochemical, and isotopic mRNA in situ hybridization study

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.61

7 January 2021

HER-2, TOP2A and chromosome 17 alterations in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.61

7 January 2021

10.1038/MODPATHOL.2009.61

Identifiers

DOI

1 reference

18 December 2017

1 reference

18 December 2017